REPH
$3.04
Recro Pharma
($.06)
(1.94%)
REPH
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.07)
Revenue:  N/A
Monday
Nov 9
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Monday, August 10, 2020
Latest EPS
Monday, August 10, 2020

What do you expect when REPH reports earnings?
Beat
Meet
Miss

Where is REPH's stock price going from here?
Up
Flat
Down
Stock chart of REPH
Analysts
Summary of analysts' recommendations for REPH
Score
Grade
Pivots
Resistance
$3.22
$3.19
$3.11

$3.08

Support
$3.00
$2.97
$2.89
Tweet
Growth
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonZoetisBristol-Myers SquibbUltragenyx PharmaceuticalCatalentMerck & Co.